WP's experience at big pharma and rolling out billion dollar drugs gives me a lot reassurance we're heading in the right direction.
Only disappointment is the slow EFS recruitment. May start, we're now in September. That's a big delay for a very small study. Hope these delays don't carry over into the pivotal study.
Eureka report, page-10
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.80 | 10 | 2 |
View Market Depth
| Last trade - 16.16pm 22/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable